Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CA 125--epitopes and molecular size.

K Nustad1, M Onsrud, B Jansson

  • 1Central Laboratory, Norwegian Radium Hospital, Oslo-Norway.

The International Journal of Biological Markers
|May 6, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isotropy of Cosmic Rays beyond 10^{20}  eV Favors Their Heavy Mass Composition.

Physical review letters·2024
Same author

Review of standard paediatric neuroradiology MRI protocols from 12 UK tertiary paediatric hospitals: is there much variation between centres?

Clinical radiology·2023
Same author

Evaluation of the Implementation of the Response Assessment in Neuro-Oncology Criteria in the HERBY Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas.

AJNR. American journal of neuroradiology·2019
Same author

A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia.

NPJ precision oncology·2018
Same author

Worth more than their weight in gold?

The British journal of dermatology·2016
Same author

Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas.

AJNR. American journal of neuroradiology·2016
Same journal

The diagnostic and predictive value of miR-145-3p in gastric cancer and its regulation of gastric cancer progression via targeting CREB1.

The International journal of biological markers·2026
Same journal

PFKP: A biomarker for prognosis, response to treatment and immune function of breast cancer.

The International journal of biological markers·2026
Same journal

Luminex assay of plasma IL-6, TNF-α, leptin, and adiponectin: Impact of anticoagulants, single-well analysis, and freeze-thaw stability.

The International journal of biological markers·2026
Same journal

Expression of concern: "RIPK4 is Downregulated in Poorly Differentiated Tongue Cancer and is Associated with Migration/Invasion and Cisplatin-Induced Apoptosis".

The International journal of biological markers·2026
Same journal

Association of NF-kappaBIA rs696 gene polymorphism with breast cancer risk in Bangladeshi women: A case-control study.

The International journal of biological markers·2026
Same journal

Circulating tumor cells and tumor-derived cell-free DNA in cancer management: Clinical evidence, limitations, and future directions.

The International journal of biological markers·2026
See all related articles

This study characterizes the CA 125 antigen, identifying distinct immunogenic areas and antibody subgroups. Understanding CA 125 epitopes is crucial for developing targeted diagnostics and therapeutics.

Area of Science:

  • Immunology
  • Biochemistry
  • Molecular Biology

Background:

  • CA 125 is a tumor-associated antigen with two primary immunogenic regions.
  • These regions are recognized by specific monoclonal antibodies, OC 125 and M11.
  • Understanding CA 125 epitopes is vital for cancer diagnostics.

Purpose of the Study:

  • To delineate the immunogenic areas of CA 125.
  • To characterize different antibody specificities and their interactions with CA 125.
  • To investigate the molecular structure and potential origins of CA 125.

Main Methods:

  • Monoclonal antibody characterization (e.g., OC 125, M11, ZR38, OV 197, 7C 12).
  • Epitope mapping and antibody binding inhibition assays.
  • Analysis of CA 125 molecular structure using SDS and heat.

Related Experiment Videos

Main Results:

  • CA 125 exhibits two main immunogenic areas defined by OC 125-like and M11-like antibodies.
  • OC 125-like antibodies form four subgroups; M11-like antibodies show numerous specificities, with ZR38 as a distinct subgroup.
  • Antibody 7C 12 induces conformational changes affecting other antibody bindings; OV 197 binding is enhanced by OC 125.

Conclusions:

  • CA 125 possesses complex immunogenic sites with diverse antibody recognition patterns.
  • The molecular structure of CA 125 is large and susceptible to disruption.
  • Serum CA 125 may represent a breakdown product of a larger molecule found in serous cavities.